VolitionRx prices public offering to raise USD 4.6 million upfront

VolitionRX Ltd

VNRX

0.00

VolitionRx priced a public offering of 2,960,000 common shares with warrants for up to 1,480,000 additional shares.
Offering price set at USD 1.55 per share with an accompanying half-warrant; expected gross proceeds about USD 4.6 million.
Warrants carry a USD 1.55 exercise price, are exercisable immediately, expire five years from issuance.
Full cash exercise could raise about USD 2.3 million in additional gross proceeds; no assurance of exercise.
Closing is expected on June 9, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VolitionRX Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-003740), on June 10, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.